Zura Bio
Brandon Walsh is currently serving as the Executive Director of Clinical Development at Zura Bio Limited. Prior to this role, Brandon held positions such as Sr. Director of Clinical Development at Arena Pharmaceuticals, Director of Clinical & Medical Affairs at Elcelyx Therapeutics Inc., and Director of Clinical Science at Zafgen, Inc. Brandon has a background in physiology, with a PhD from The Karolinska Institute. Throughout his career, Brandon has displayed strong technical skills in various software and systems, as well as organizational and leadership skills in managing multiple writing projects and scientific disclosure planning processes.
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.